Jeonjinbio Co. Ltd (110020) — Capital Reinvestment Ratio

Latest as of September 2025: 0.03x

Jeonjinbio Co. Ltd (110020) has a Capital Reinvestment Ratio of 0.03x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩313.21 Million) in capital expenditures (₩10.04 Million). Check tangible equity quality of Jeonjinbio Co. Ltd to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.03x

Capex / Operating Cash Flow

Operating Cash Flow

₩313.21 Million

KRW

Capital Expenditures

₩10.04 Million

KRW

Data as of

Sep 2025

Most recent filing

Jeonjinbio Co. Ltd Capital Reinvestment Ratio (2024–2024)

This chart tracks Jeonjinbio Co. Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Jeonjinbio Co. Ltd generate cash.

Annual Capital Reinvestment Ratio for Jeonjinbio Co. Ltd (2024–2024)

Year-by-year Capital Reinvestment Ratio for Jeonjinbio Co. Ltd from 2024 to 2024. See Jeonjinbio Co. Ltd (110020) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change
2024	0.13x	₩3.01 Billion	₩394.36 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow